H. Yetişkin Et Al. , "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2," FRONTIERS IN IMMUNOLOGY , vol.13, pp.824378, 2022
Yetişkin, H. Et Al. 2022. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2. FRONTIERS IN IMMUNOLOGY , vol.13 , 824378.
Yetişkin, H., Kaplan, B., Pavel, S. T. I., & Özdarendeli, A., (2022). Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2. FRONTIERS IN IMMUNOLOGY , vol.13, 824378.
Yetişkin, HAZEL Et Al. "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2," FRONTIERS IN IMMUNOLOGY , vol.13, 824378, 2022
Yetişkin, HAZEL Et Al. "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2." FRONTIERS IN IMMUNOLOGY , vol.13, pp.824378, 2022
Yetişkin, H. Et Al. (2022) . "Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2." FRONTIERS IN IMMUNOLOGY , vol.13, p.824378.
@article{article, author={HAZEL YETİŞKİN Et Al. }, title={Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2}, journal={FRONTIERS IN IMMUNOLOGY}, year=2022, pages={824378} }